Results 221 to 230 of about 2,123,606 (402)

Signature of mitochondria of steroidal hormones-dependent normal and cancer cells: potential molecular targets for cancer therapy [PDF]

, 2006
Deodutta Roy
openalex   +1 more source

Molecular Targets for Breast Cancer Therapy

Biomolecules
Breast cancer is by far the most common cancer in women, and for a while, it surpassed lung cancer as the most diagnosed cancer, regardless of gender, in 2020 [...]
openaire   +4 more sources

Multiplex single‐cell profiling of putative cancer stem cell markers ALDH1, SOX9, SOX2, CD44, CD133 and CD15 in endometrial cancer

Molecular Oncology, EarlyView.
Cancer stem cells are associated with aggressive disease, but a deep characterization of such markers is lacking in endometrial cancer. This study uses imaging mass cytometry to explore putative cancer stem cell markers in endometrial tumors and corresponding organoid models.
Hilde E. Lien, Marta E. Hjelmeland, Hege F. Berg, Rose M. Gold, Kathrine Woie, Lars A. Akslen, Ingfrid S. Haldorsen, Camilla Krakstad   +7 more
wiley   +1 more source

Molecular targeted therapy in myeloma and lymphoma [PDF]

, 2014
Maeda, Yoshinobu, Saeki, Kyosuke, Tanimoto, Mitsune   +2 more
core   +1 more source

Enzalutamide Sensitizes Castration‐Resistant Prostate Cancer to Copper‐Mediated Cell Death

Advanced Science
Despite the initial efficacy of enzalutamide in castration‐resistant prostate cancer (CRPC), inevitable resistance remains a significant challenge. Here, the synergistic induction of copper‐dependent cell death (cuproptosis) in CRPC cells is reported by ...
Xiang Gao, Haolin Zhao, Jiao Liu, Min Wang, Zhihong Dai, Wenjun Hao, Yanlong Wang, Xiang Wang, Min Zhang, Pixu Liu, Hailing Cheng, Zhiyu Liu   +11 more
doaj   +1 more source

Epigenetic modifications in follicular cell-derived thyroid cancer: new dimensions in pathogenesis and treatment

Frontiers in Oncology
The incidence of thyroid cancer has been rising in recent years. While tumorigenesis has traditionally been attributed to the accumulation of genetic mutations in oncogenes and tumor suppressor genes, increasing attention has been directed toward the ...
Yanmei Han, Yanmei Han, Yanmei Han, Bian Wu, Jie Tan, Ruolin Wu, Ruolin Wu, Ruolin Wu, Jingjing Wang, Jingjing Wang, Jingjing Wang, Xiaojing Ren, Xiaojing Ren, Xiaojing Ren, Yajing Zhang, Yajing Zhang, Yajing Zhang, Zairong Gao, Zairong Gao, Zairong Gao, Xiaotian Xia, Xiaotian Xia, Xiaotian Xia   +22 more
doaj   +1 more source

Minireview: The Brain as a Molecular Target for Diabetic Therapy [PDF]

, 2006
Elena Prodi, Silvana Obici
openalex   +1 more source

Peripheral blood proteome biomarkers distinguish immunosuppressive features of cancer progression

Molecular Oncology, EarlyView.
Immune status significantly influences cancer progression. This study used plasma proteomics to analyze benign 67NR and malignant 4T1 breast tumor models at early and late tumor stages. Immune‐related proteins–osteopontin (Spp1), lactotransferrin (Ltf), calreticulin (Calr) and peroxiredoxin 2 (Prdx2)–were associated with systemic myeloid‐derived ...
Yeon Ji Park, Jae Won Oh, Hyewon Chung, Jung Won Kwon, Yi Rang Na, Kwang Pyo Kim, Seung Hyeok Seok   +6 more
wiley   +1 more source

Akt Is a Molecular Target for Signal Transduction Therapy in Brain Ischemic Insult

, 2003
Kohji Fukunaga, Takayuki Kawano
openalex   +2 more sources

A New Melanoma Antigen Fatty Acid–Binding Protein 7, Involved in Proliferation and Invasion, Is a Potential Target for Immunotherapy and Molecular Target Therapy [PDF]

, 2006
Yasufumi Goto, Yuriko Matsuzaki, Sachiko Kurihara, Ayako Shimizu, Tsutomu Okada, Kazuhiko Yamamoto, Hiroshi Murata, Minoru Takata, Hiroyuki Aburatani, Dave S.�B. Hoon, Toshiaki Saida, Yutaka Kawakami   +11 more
openalex   +1 more source